Militello John 4

What Happened John Militello, Vice President of Finance, Treasurer and Principal Accounting Officer at Rocket Pharmaceuticals (RCKT), sold 1,157 shares of common stock on 2026-02-18 in an open-market/private sale. The shares were sold at $3.34 per share for total proceeds of $3,862. The filing indicates the sale was made to satisfy tax withholding obligations related to vested Restricted Stock Units (RSUs).

Key Details

• Transaction date: 2026-02-18; filing date: 2026-02-20 (timely filing).
• Transaction type/code: Sale (S).
• Shares sold: 1,157 at $3.34 per share; total value $3,862.
• Reason: Sold to pay tax withholding on RSU vesting (footnote F2).
• Holdings note: Reported holdings include RSUs that convert one-for-one to common stock (footnote F1).
• Shares owned after transaction: Not specified in the provided excerpt.

Context

• This was a withholding-related sale tied to RSU vesting, a common and routine reason for insider sales that does not necessarily signal a change in insider sentiment.
• No option exercises, gifts, or 10% owner transfers are indicated in this filing.